Experimental infection and protection against ... - TI Pharma

254 Chapter 12
Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J,
Arens T, Beckers P, van Gemert G, van de Vegte-Bolmer M, van der Ven AJ, Luty
AJ, Hermsen CC, Sauerwein RW. Long-term protection against malaria after
experimental sporozoite inoculation: an open-label follow-up study. Lancet.
2011 May 21;377(9779):1770-6.
Sauerwein RW, Roestenberg M, Moorthy VS. Experimental human challenge
infections can accelerate clinical malaria vaccine development. Nat Rev
Immunol. 2011 Jan;11(1):57-64.
McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, de Mast Q, Dolo
A, Doumbo OK, Luty A, van der Ven AJ, Hermsen CC, Sauerwein RW. Memorylike
IFN-γ response by NK cells following malaria infection reveals the crucial role
of T cells in NK cell activation by P. falciparum. Eur J Immunol. 2010
Dec;40(12):3472-7.
de Mast Q, de Groot PG, van Heerde WL, Roestenberg M, van Velzen JF,
Verbruggen B, Roest M, McCall M, Nieman AE, Westendorp J, Syafruddin D,
Fijnheer R, van Dongen-Lases EC, Sauerwein RW, van der Ven AJ.
Thrombocytopenia in early malaria is associated with GP1b shedding in absence
of systemic platelet activation and consumptive coagulopathy. Br J Haematol.
2010 Dec;151(5):495-503.
Nieman AE, de Mast Q, Roestenberg M, Wiersma J, Pop G, Stalenhoef A, Druilhe
P, Sauerwein R, van der Ven A. Cardiac complication after experimental human
malaria infection: a case report. Malar J. 2009 Dec 3;8:277.
Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de
Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q,
Roeffen W, Snounou G, Rénia L, van der Ven A, Hermsen CC, Sauerwein R.
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med.
2009 Jul 30;361(5):468-77.
de Mast Q, van Dongen-Lases EC, Swinkels DW, Nieman AE, Roestenberg M,
Druilhe P, Arens TA, Luty AJ, Hermsen CC, Sauerwein RW, van der Ven AJ. Mild
increases in serum hepcidin and interleukin-6 concentrations impair iron
incorporation in haemoglobin during an experimental human malaria infection.
Br J Haematol. 2009 Jun;145(5):657-64.
Roestenberg M, Remarque E, de Jonge E, Hermsen R, Blythman H, Leroy O,
Imoukhuede E, Jepsen S, Ofori-Anyinam O, Faber B, Kocken CH, Arnold M,
Walraven V, Teelen K, Roeffen W, de Mast Q, Ballou WR, Cohen J, Dubois MC,
Ascarateil S, van der Ven A, Thomas A, Sauerwein R. Safety and immunogenicity
of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted
with Alhydrogel, Montanide ISA 720 or AS02. PLoS One. 2008;3(12):e3960.
Roestenberg M, McCall M, Mollnes TE, van Deuren M, Sprong T, Klasen I,
Hermsen CC, Sauerwein RW, van der Ven A. Complement activation in